Preferred Label : Pembrolizumab Regimen;
NCIt synonyms : Keytruda Regimen;
NCIt related terms : Pembrolizumab monotherapy;
NCIt definition : A regimen consisting of pembrolizumab that may be used in the treatment of anal, anaplastic,
Merkel cell, and thymic carcinomas; ampullary, appendiceal, pancreatic, and small
bowel adenocarcinomas; alveolar soft part sarcoma; soft tissue sarcoma, uterine sarcoma,
and Kaposi sarcoma; bladder, breast, esophageal and esophagogastric junction, kidney,
occult primary, gastric, bone, colorectal, cervical, non-small cell lung, small cell
lung, penile, testicular, prostate, hepatobiliary, endometrial, vaginal, vulvar, ovarian,
fallopian tube and primary peritoneal cancers; head and neck cancer including cancer
of the nasopharynx; gestational trophoblastic neoplasia; chronic lymphocytic leukemia
(CLL); small lymphocytic lymphoma (SLL); diffuse large B-cell lymphoma (DLBCL); Hodgkin
lymphoma; T-cell lymphomas; mycosis fungoides/Sezary syndrome; follicular, medullary,
papillary and Hurthle cell thyroid carcinomas; malignant germ cell tumors; adrenal
gland and neuroendocrine tumors (NETs); extrapulmonary poorly differentiated neuroendocrine
carcinoma, large or small cell carcinoma, and mixed neuroendocrine-non-neuroendocrine
neoplasm; squamous cell skin cancer; and cutaneous and uveal melanoma.;
NCI Metathesaurus CUI : CL969182;
Codes from synonyms : 3199;
Origin ID : C160108;
UMLS CUI : C5204945;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
https://pgtmsite.files.wordpress.com/2024/01/protocole-ad-pembrolizumab_final.pdf
2020
Canada
drug information
pembrolizumab
pembrolizumab
pembrolizumab
Pembrolizumab Regimen
AD Regimen
---
